On the sidelines of the Antique Investor Conference, Yogesh Agrawal, Md of Ajanta Pharma told CNBC-TV18 that the company has filed for 5 Abbreviated New Drug Application‘s (ANDA) of which 2 tentative approvals may be launched in the near future.
first published: Feb 16, 2016 01:04 pm
A collection of the most-viewed Moneycontrol videos.
Live: Nifty snaps 4-week gains, slips below 25,800 | Closing Bell
Live: Is Nifty likely to stay in profit-booking mode? | Opening Bell
Groww CEO Lalit Keshre on ₹62,000 Crore IPO, Sebi regulations, valuation expectation and more
How Income Plus Arbitrage Fund of Fund Can Help You Get Stable, Tax-Efficient Returns
